Finance

Beta
Lists
C1P:FRA
Consun Pharmaceutical Group Ltd
€1.46
-0.68%
(-0.0100) 1D
Jun 12, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C1P...
Open
€1.46
High
€1.58
Low
€1.46
Mkt. cap
11.59B
Avg. vol.
190.00
Volume
4.00
52-wk high
€2.18
52-wk low
€1.04
No. of employees
3K
Open
€1.46
High
€1.58
Low
€1.46
Mkt. cap
11.59B
Avg. vol.
190.00
Volume
4.00
52-wk high
€2.18
52-wk low
€1.04
No. of employees
3K
News stories
From sources across the web
About Consun Pharmaceutical Group Ltd
CEO-
Employees3.12K
Founded1997
Headquarters-
SectorPharmaceutical industry
Websitechinaconsun.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
784.29M
784.29M
924.38M
924.38M
Cost of goods sold
179.95M
179.95M
195.16M
195.16M
Cost of revenue
179.95M
179.95M
195.16M
195.16M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
346.61M
346.61M
412.59M
412.59M
Operating expense
346.95M
346.95M
410.59M
410.59M
Total operating expenses
526.90M
526.90M
605.75M
605.75M
Operating income
257.39M
257.39M
318.63M
318.63M
Other non operating income
-
-
-
-
EBT including unusual items
267.62M
267.62M
330.59M
330.59M
EBT excluding unusual items
267.79M
267.79M
331.38M
331.38M
Income tax expense
16.19M
16.19M
37.45M
37.45M
Effective tax rate
6.05%
6.05%
11.33%
11.33%
Other operating expenses
32.50K
32.50K
-1.19M
-1.19M
Net income
249.15M
249.15M
289.88M
289.88M
Net profit margin
31.77%
31.77%
31.36%
31.36%
Earnings per share
-
-
-
-
Interest and investment income
21.53M
21.53M
21.11M
21.11M
Interest expense
-1.23M
-1.23M
-946.00K
-946.00K
Net interest expenses
20.30M
20.30M
20.16M
20.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
271.56M
271.56M
332.28M
332.28M
Gain or loss from assets sale
-
-
965.50K
965.50K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer